Your browser doesn't support javascript.
loading
Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women.
Cunningham, C K; Wara, D W; Kang, M; Fenton, T; Hawkins, E; McNamara, J; Mofenson, L; Duliege, A M; Francis, D; McFarland, E J; Borkowsky, W.
Affiliation
  • Cunningham CK; Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA. cunningc@mail.upstate.edu
Clin Infect Dis ; 32(5): 801-7, 2001 Mar 01.
Article in En | MEDLINE | ID: mdl-11229849
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Envelope Protein gp120 / HIV Infections / AIDS Vaccines / Infectious Disease Transmission, Vertical Type of study: Clinical_trials Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: HIV Envelope Protein gp120 / HIV Infections / AIDS Vaccines / Infectious Disease Transmission, Vertical Type of study: Clinical_trials Limits: Female / Humans / Newborn / Pregnancy Language: En Journal: Clin Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2001 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos